ClinConnect ClinConnect Logo

Main Menu

Search for Trials
For HCPs
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up
Search / Trial NCT00002520

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Launched by EASTERN COOPERATIVE ONCOLOGY GROUP · Aug 8, 2003

Download PDF Apply for Trial

Trial Information

Current as of May 24, 2025

Completed

Keywords

Stage I Adult Hodgkin Lymphoma Angioimmunoblastic T Cell Lymphoma Stage Ii Adult Hodgkin Lymphoma Stage Iii Adult Hodgkin Lymphoma Stage Iv Adult Hodgkin Lymphoma Stage I Colon Cancer Stage Ii Colon Cancer Stage I Breast Cancer Aids Related Peripheral/Systemic Lymphoma Aids Related Primary Cns Lymphoma Anaplastic Large Cell Lymphoma Contiguous Stage Ii Adult Diffuse Large Cell Lymphoma Contiguous Stage Ii Adult Diffuse Mixed Cell Lymphoma Contiguous Stage Ii Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage Ii Adult Burkitt Lymphoma Contiguous Stage Ii Adult Immunoblastic Large Cell Lymphoma Contiguous Stage Ii Adult Lymphoblastic Lymphoma Contiguous Stage Ii Grade 1 Follicular Lymphoma Contiguous Stage Ii Grade 2 Follicular Lymphoma Contiguous Stage Ii Grade 3 Follicular Lymphoma Contiguous Stage Ii Mantle Cell Lymphoma Intraocular Lymphoma Limited Stage Small Cell Lung Cancer Noncontiguous Stage Ii Adult Diffuse Large Cell Lymphoma Noncontiguous Stage Ii Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage Ii Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage Ii Adult Burkitt Lymphoma Noncontiguous Stage Ii Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage Ii Adult Lymphoblastic Lymphoma Noncontiguous Stage Ii Grade 1 Follicular Lymphoma Noncontiguous Stage Ii Grade 2 Follicular Lymphoma Noncontiguous Stage Ii Grade 3 Follicular Lymphoma Noncontiguous Stage Ii Mantle Cell Lymphoma Primary Central Nervous System Lymphoma Tobacco Use Disorder Stage I Adenoid Cystic Carcinoma Of The Oral Cavity Stage I Adult T Cell Leukemia/Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Basal Cell Carcinoma Of The Lip Stage I Cutaneous T Cell Non Hodgkin Lymphoma Stage I Esthesioneuroblastoma Of The Paranasal Sinus And Nasal Cavity Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Inverted Papilloma Of The Paranasal Sinus And Nasal Cavity Stage I Lymphoepithelioma Of The Nasopharynx Stage I Lymphoepithelioma Of The Oropharynx Stage I Mantle Cell Lymphoma Stage I Midline Lethal Granuloma Of The Paranasal Sinus And Nasal Cavity Stage I Mucoepidermoid Carcinoma Of The Oral Cavity Stage I Mycosis Fungoides/Sezary Syndrome Stage I Non Small Cell Lung Cancer Stage I Prostate Cancer Stage I Rectal Cancer Stage I Squamous Cell Carcinoma Of The Hypopharynx Stage I Squamous Cell Carcinoma Of The Larynx Stage I Squamous Cell Carcinoma Of The Lip And Oral Cavity Stage I Squamous Cell Carcinoma Of The Nasopharynx Stage I Squamous Cell Carcinoma Of The Oropharynx Stage I Squamous Cell Carcinoma Of The Paranasal Sinus And Nasal Cavity Stage I Malignant Testicular Germ Cell Tumor Stage I Verrucous Carcinoma Of The Larynx Stage I Verrucous Carcinoma Of The Oral Cavity Stage Ii Adult T Cell Leukemia/Lymphoma Stage Ii Adenoid Cystic Carcinoma Of The Oral Cavity Stage Ii Basal Cell Carcinoma Of The Lip Stage Ii Bladder Cancer Stage Ii Breast Cancer Stage Ii Cutaneous T Cell Non Hodgkin Lymphoma Stage Ii Esthesioneuroblastoma Of The Paranasal Sinus And Nasal Cavity Stage Ii Inverted Papilloma Of The Paranasal Sinus And Nasal Cavity Stage Ii Lymphoepithelioma Of The Nasopharynx Stage Ii Lymphoepithelioma Of The Oropharynx Stage Ii Midline Lethal Granuloma Of The Paranasal Sinus And Nasal Cavity Stage Ii Mucoepidermoid Carcinoma Of The Oral Cavity Stage Ii Mycosis Fungoides/Sezary Syndrome Stage I Bladder Cancer Stage Ii Non Small Cell Lung Cancer Stage Ii Prostate Cancer Stage Ii Rectal Cancer Stage Ii Squamous Cell Carcinoma Of The Hypopharynx Stage Ii Squamous Cell Carcinoma Of The Larynx Stage Ii Squamous Cell Carcinoma Of The Lip And Oral Cavity Stage Ii Squamous Cell Carcinoma Of The Nasopharynx Stage Ii Squamous Cell Carcinoma Of The Oropharynx Stage Ii Squamous Cell Carcinoma Of The Paranasal Sinus And Nasal Cavity Stage Ii Malignant Testicular Germ Cell Tumor Stage Ii Verrucous Carcinoma Of The Larynx Stage Ii Verrucous Carcinoma Of The Oral Cavity Stage Iii Adult T Cell Leukemia/Lymphoma Stage Iii Adult Diffuse Large Cell Lymphoma Stage Iii Adult Diffuse Mixed Cell Lymphoma Stage Iii Adult Diffuse Small Cleaved Cell Lymphoma Stage Iii Adult Burkitt Lymphoma Stage Iii Adult Immunoblastic Large Cell Lymphoma Stage Iii Adult Lymphoblastic Lymphoma Stage Iii Cutaneous T Cell Non Hodgkin Lymphoma Stage Iii Grade 1 Follicular Lymphoma Stage Iii Grade 2 Follicular Lymphoma Stage Iii Grade 3 Follicular Lymphoma Stage Iii Mantle Cell Lymphoma Stage Iii Mycosis Fungoides/Sezary Syndrome Stage Iii Prostate Cancer Stage Iii Malignant Testicular Germ Cell Tumor Stage Iiia Breast Cancer Stage Iiib Breast Cancer Stage Iv Adult T Cell Leukemia/Lymphoma Stage Iv Adult Diffuse Large Cell Lymphoma Stage Iv Adult Diffuse Mixed Cell Lymphoma Stage Iv Adult Diffuse Small Cleaved Cell Lymphoma Stage Iv Adult Burkitt Lymphoma Stage Iv Adult Immunoblastic Large Cell Lymphoma Stage Iv Adult Lymphoblastic Lymphoma Stage Iv Breast Cancer Stage Iv Cutaneous T Cell Non Hodgkin Lymphoma Stage Iv Grade 1 Follicular Lymphoma Stage Iv Grade 2 Follicular Lymphoma Stage Iv Grade 3 Follicular Lymphoma Stage Iv Mantle Cell Lymphoma Stage Iv Mycosis Fungoides/Sezary Syndrome Stage Iv Prostate Cancer Unspecified Adult Solid Tumor, Protocol Specific Contiguous Stage Ii Marginal Zone Lymphoma Contiguous Stage Ii Small Lymphocytic Lymphoma Noncontiguous Stage Ii Small Lymphocytic Lymphoma Noncontiguous Stage Ii Marginal Zone Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage Iii Small Lymphocytic Lymphoma Stage Iii Marginal Zone Lymphoma Stage Iv Small Lymphocytic Lymphoma Stage Iv Marginal Zone Lymphoma Extranodal Marginal Zone B Cell Lymphoma Of Mucosa Associated Lymphoid Tissue Nodal Marginal Zone B Cell Lymphoma Splenic Marginal Zone Lymphoma

ClinConnect Summary

OBJECTIVES:

* Compare the efficacy of brief physician-initiated smoking cessation strategies vs usual care in patients with early stage cancer who are undergoing treatment in clinical oncology settings.
* Compare the sociodemographic, smoking history, and health status correlates of smoking cessation in patients treated with these regimens.
* Determine the feasibility of conducting a cancer prevention and control study in a cooperative group setting by monitoring adherence to the smoking-cessation strategies.

OUTLINE: This is a randomized, multicenter study. Patients are stratified accord...

Gender

ALL

Eligibility criteria

  • DISEASE CHARACTERISTICS:
  • * One of the following diagnoses:
  • • Stage I or II bladder, colorectal, head and neck, lung, or other cancer
  • • Stage I-III testicular cancer
  • • Stage I-IV breast cancer, prostate cancer, or lymphoma
  • • Must have smoked 1 or more cigarettes within the past month or define self as a smoker
  • * Hormone receptor status:
  • • Not specified
  • PATIENT CHARACTERISTICS:
  • Age:
  • • 19 and over
  • Sex:
  • • Not specified
  • Menopausal status:
  • • Not specified
  • Performance status:
  • • ECOG 0-1
  • Life expectancy:
  • • Not specified
  • Hematopoietic:
  • • Not specified
  • Hepatic:
  • • Not specified
  • Renal:
  • • Not specified
  • Cardiovascular:
  • • No history of recent heart attack
  • Other:
  • • Not pregnant
  • • No other imminent medical needs requiring referral to a more intensive smoking cessation regimen
  • PRIOR CONCURRENT THERAPY:
  • Biologic therapy:
  • • Not specified
  • Chemotherapy:
  • • Not specified
  • Endocrine therapy:
  • • Not specified
  • Radiotherapy:
  • • Not specified
  • Surgery:
  • • Not specified
  • Other:
  • • No prior participation in the pilot phase study

About Eastern Cooperative Oncology Group

The Eastern Cooperative Oncology Group (ECOG) is a prominent clinical trial sponsor dedicated to advancing cancer research and improving patient outcomes through collaborative studies. Established in 1955, ECOG is a leading network of academic and community-based researchers who design and conduct multicenter clinical trials across various cancer types. With a focus on innovative treatment approaches, prevention strategies, and supportive care interventions, ECOG engages healthcare professionals and institutions nationwide. The group's commitment to rigorous scientific methodology and patient-centered care aims to enhance the understanding of cancer and foster the development of transformative therapies that benefit patients and the broader oncology community.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Paul F. Engstrom, MD

Study Chair

Fox Chase Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials